View in EDS PDF Full Text

Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma.

Saved in:
Bibliographic Details
Title: Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma.
Authors: Mørk SK; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Kadivar M; Department of Health Technology, Technical University of Denmark- DTU, HEALTH TECH, Lyngby, Denmark., Bol KF; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Draghi A; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Westergaard MCW; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Skadborg SK; Department of Health Technology, Technical University of Denmark- DTU, HEALTH TECH, Lyngby, Denmark., Overgaard N; Department of Health Technology, Technical University of Denmark- DTU, HEALTH TECH, Lyngby, Denmark., Sørensen AB; Evaxion Biotech A/S, Denmark., Rasmussen IS; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark., Andreasen LV; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark., Yde CW; Diagnostic Center Rigshospitalet, Genomic Medicine Rigshospitalet, Copenhagen, Denmark., Trolle T; Evaxion Biotech A/S, Denmark., Garde C; Evaxion Biotech A/S, Denmark., Friis-Nielsen J; Evaxion Biotech A/S, Denmark., Nørgaard N; Department of Urology, Copenhagen University Hospital, Herlev, Denmark., Christensen D; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark., Kringelum JV; Evaxion Biotech A/S, Denmark., Donia M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Hadrup SR; Department of Health Technology, Technical University of Denmark- DTU, HEALTH TECH, Lyngby, Denmark., Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
Source: Oncoimmunology [Oncoimmunology] 2022 Jan 10; Vol. 11 (1), pp. 2023255. Date of Electronic Publication: 2022 Jan 10 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2162-402X
DOI:10.1080/2162402X.2021.2023255